The latest data from the phase 1 trial are encouraging,” said the study's lead author.
A new type of mRNA vaccine, added to standard cancer treatment, could help some patients with pancreatic cancer live longer.
A new study from Memorial Sloan Kettering Cancer Center shows good results for patients with pancreatic cancer. They used a ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback